A retrospective analysis of the efficacy and adverse reactions for the renal trans-plant patients conversed from cyclosporine A to tacrolimus
10.3969/j.issn.1006-0111.2018.01.016
- VernacularTitle:肾移植患者用他克莫司替换环孢素A后的疗效及不良反应的回顾性分析
- Author:
Zewu WEI
1
;
Wenwen ZHANG
;
Duoling MA
;
Juan BI
;
Jiexiu CHEN
;
Yunyun YANG
Author Information
1. 第二军医大学附属长海医院药学部
- Keywords:
tacrolimus;
cyclosporine A;
kidney transplantation;
drug induced disease;
acute rejection
- From:
Journal of Pharmaceutical Practice
2018;36(1):75-79
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy and adverse reactions for renal transplant patients conversed from cyclospo-rine A to tacrolimus .Methods The follow-up data of renal transplant patients conversed from cyclosporine A to tacrolimus were collected .The clinical therapeutic outcomes including drug induced diseases (DIDs) and acute rejection (AR) induced by cyclosporine A were analyzed during the first year after conversion with SPSS 17 .0 software .Results The levels of Scr and BUN were significantly decreased during the first year after conversion for renal transplant patients with CScr and AR (P<0.05 or P<0 .01) .The levels of direct bilirubin (DB) and total bilirubin (TB) were also significantly lowed (P<0.05 or P<0 .01) during the first year for drug-induced liver injury (DILI) patients .The average level of ALT was significantly decreased in 12 months after conversion (P<0.05) .The complications of gingival overgrowth (GO) stopped with the medication replace-ment .However ,the fasting blood glucose (FBG) level increased significantly in 12 months after conversion (P<0.05) .Con-clusion For renal transplant patients suffered from AR or the serious DIDs induced by cyclosporine A ,conversion from cyclos-porine A to tacrolimus could be considered .However ,it should be aware of the high blood glucose or the new diabetes caused by tacrolimus .
